Anthem (NYSE:ANTM) Releases FY 2021 Earnings Guidance

Anthem (NYSE:ANTM) issued an update on its FY 2021 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $25.500-$ for the period, compared to the Thomson Reuters consensus estimate of $25.650. The company issued revenue guidance of -.

A number of analysts have weighed in on the stock. Mizuho increased their price target on shares of Anthem from $380.00 to $385.00 and gave the company a neutral rating in a report on Thursday, July 22nd. They noted that the move was a valuation call. Seaport Global Securities assumed coverage on shares of Anthem in a report on Friday, July 9th. They issued a buy rating and a $430.00 price target for the company. Stephens increased their price target on shares of Anthem from $430.00 to $440.00 and gave the company an overweight rating in a report on Thursday, July 22nd. Seaport Res Ptn reissued a buy rating on shares of Anthem in a report on Friday, July 9th. Finally, Cantor Fitzgerald raised their price objective on shares of Anthem from $430.00 to $455.00 and gave the stock an overweight rating in a report on Thursday, July 22nd. Two investment analysts have rated the stock with a hold rating and nineteen have issued a buy rating to the company. According to, the company presently has an average rating of Buy and an average price target of $419.76.

ANTM traded up $1.03 during midday trading on Friday, hitting $381.33. The company had a trading volume of 655,288 shares, compared to its average volume of 1,163,089. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.49 and a current ratio of 1.49. The company has a market capitalization of $92.97 billion, a PE ratio of 22.40, a P/E/G ratio of 1.07 and a beta of 1.03. Anthem has a twelve month low of $246.20 and a twelve month high of $406.00. The firm’s 50-day simple moving average is $377.40 and its 200-day simple moving average is $377.49.

Anthem (NYSE:ANTM) last issued its quarterly earnings results on Tuesday, July 20th. The company reported $7.03 EPS for the quarter, topping the consensus estimate of $6.34 by $0.69. Anthem had a net margin of 3.27% and a return on equity of 15.24%. The company had revenue of $33.28 billion during the quarter, compared to analysts’ expectations of $33.22 billion. During the same quarter in the previous year, the company earned $9.20 EPS. Anthem’s revenue was up 14.1% on a year-over-year basis. As a group, sell-side analysts anticipate that Anthem will post 25.6 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Friday, September 24th. Shareholders of record on Friday, September 10th were paid a $1.13 dividend. This represents a $4.52 dividend on an annualized basis and a yield of 1.19%. The ex-dividend date was Thursday, September 9th. Anthem’s payout ratio is currently 20.11%.

In related news, Director Ryan M. Schneider purchased 1,300 shares of the business’s stock in a transaction on Friday, July 23rd. The shares were purchased at an average price of $384.36 per share, with a total value of $499,668.00. Following the completion of the purchase, the director now owns 4,714 shares in the company, valued at approximately $1,811,873.04. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.28% of the company’s stock.

An institutional investor recently raised its position in Anthem stock. Morgan Stanley increased its position in shares of Anthem, Inc. (NYSE:ANTM) by 7.8% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,568,625 shares of the company’s stock after buying an additional 113,659 shares during the period. Morgan Stanley owned 0.64% of Anthem worth $598,899,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 86.69% of the company’s stock.

About Anthem

Anthem, Inc provides life, hospital and medical insurance plans. It offers a broad spectrum of network-based managed care health benefit plans to the large and small employer, individual, Medicaid, and Medicare markets. The company operates through the following segments: Commercial & Specialty Business, Government Business, IngenioRx and Other.

Recommended Story: What are economic reports?

Earnings History and Estimates for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with's FREE daily email newsletter.